Literature DB >> 20437566

Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain.

Eugene V Grishin1, Ganna A Savchenko, Alexander A Vassilevski, Yuliya V Korolkova, Yaroslav A Boychuk, Viacheslav Y Viatchenko-Karpinski, Kirill D Nadezhdin, Alexander S Arseniev, Kirill A Pluzhnikov, Vyacheslav B Kulyk, Nana V Voitenko, Oleg O Krishtal.   

Abstract

P2X3 purinoreceptors expressed in mammalian sensory neurons play a key role in several processes, including pain perception. From the venom of the Central Asian spider Geolycosa sp., we have isolated a novel peptide, named purotoxin-1 (PT1), which is to our knowledge the first natural molecule exerting powerful and selective inhibitory action on P2X3 receptors. PT1 dramatically slows down the removal of desensitization of these receptors. The peptide demonstrates potent antinociceptive properties in animal models of inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20437566     DOI: 10.1002/ana.21949

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.

Authors:  David Richards; Joel R Gever; Anthony P Ford; Samuel J Fountain
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

2.  Sea anemone peptide with uncommon β-hairpin structure inhibits acid-sensing ion channel 3 (ASIC3) and reveals analgesic activity.

Authors:  Dmitry I Osmakov; Sergey A Kozlov; Yaroslav A Andreev; Sergey G Koshelev; Nadezhda P Sanamyan; Karen E Sanamyan; Igor A Dyachenko; Dmitry A Bondarenko; Arkadii N Murashev; Konstantin S Mineev; Alexander S Arseniev; Eugene V Grishin
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

Review 3.  Anticancer, antimicrobial, and analgesic activities of spider venoms.

Authors:  Hassan M Akef
Journal:  Toxicol Res (Camb)       Date:  2018-03-08       Impact factor: 3.524

4.  Pyrid-2-yl and 2-CyanoPhenyl fused heterocyclic compounds as human P2X3 inhibitors: a combined approach based on homology modelling, docking and QSAR analysis.

Authors:  Sridhara Janardhan; Subhendu Seth; Vellarkad N Viswanadhan
Journal:  Mol Divers       Date:  2013-10-24       Impact factor: 2.943

5.  Molecular mechanism for opioid dichotomy: bidirectional effect of μ-opioid receptors on P2X₃ receptor currents in rat sensory neurones.

Authors:  Igor Chizhmakov; Vyacheslav Kulyk; Iryna Khasabova; Sergey Khasabov; Donald Simone; Georgy Bakalkin; Dmitri Gordienko; Alexei Verkhratsky; Oleg Krishtal
Journal:  Purinergic Signal       Date:  2015-01-16       Impact factor: 3.765

6.  Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.

Authors:  Anatoly Shcherbatko; Davide Foletti; Kris Poulsen; Pavel Strop; Guoyun Zhu; Adela Hasa-Moreno; Jody Melton Witt; Carole Loo; Stellanie Krimm; Ariel Pios; Jessica Yu; Colleen Brown; John K Lee; Robert Stroud; Arvind Rajpal; David Shelton
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

7.  Lignan from thyme possesses inhibitory effect on ASIC3 channel current.

Authors:  Maxim A Dubinnyi; Dmitry I Osmakov; Sergey G Koshelev; Sergey A Kozlov; Yaroslav A Andreev; Naira A Zakaryan; Igor A Dyachenko; Dmitry A Bondarenko; Alexander S Arseniev; Eugene V Grishin
Journal:  J Biol Chem       Date:  2012-08-01       Impact factor: 5.157

Review 8.  Spider-venom peptides as therapeutics.

Authors:  Natalie J Saez; Sebastian Senff; Jonas E Jensen; Sing Yan Er; Volker Herzig; Lachlan D Rash; Glenn F King
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546

Review 9.  From toxins targeting ligand gated ion channels to therapeutic molecules.

Authors:  Adak Nasiripourdori; Valérie Taly; Thomas Grutter; Antoine Taly
Journal:  Toxins (Basel)       Date:  2011-03-21       Impact factor: 4.546

10.  A Comparative Analysis of the Venom Gland Transcriptomes of the Fishing Spiders Dolomedes mizhoanus and Dolomedes sulfurous.

Authors:  Xunxun Xu; Hengyun Wang; Fang Zhang; Zhaotun Hu; Songping Liang; Zhonghua Liu
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.